In an era of increasingly bespoke healthcare, Elizabeth Philp has emerged as a significant force of innovation, particularly in the tech-driven field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the forefront of a movement to make custom medications more available, disrupting the standard one-size-fits